These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37221640)

  • 21. Liver transplantation for viral hepatitis in 2015.
    Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
    World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030.
    Sintusek P; Thanapirom K; Komolmit P; Poovorawan Y
    World J Gastroenterol; 2022 Jan; 28(3):290-309. PubMed ID: 35110951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of liver transplantation in acute liver failure caused by viral hepatitis.
    Raakow R; Blumhardt G; Kling N; Bechstein WO; Lohmann R; Neuhaus P
    Transpl Int; 1994; 7 Suppl 1():S227-8. PubMed ID: 11271210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan.
    Liao SH; Chen CL; Hsu CY; Chien KL; Kao JH; Chen PJ; Chen TH; Chen CH
    J Hepatol; 2021 Jul; 75(1):132-141. PubMed ID: 33689789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status and strategies for viral hepatitis control in Korea.
    Sinn DH; Cho EJ; Kim JH; Kim DY; Kim YJ; Choi MS
    Clin Mol Hepatol; 2017 Sep; 23(3):189-195. PubMed ID: 28942620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current impact of viral hepatitis on liver cancer development: The challenge remains.
    de Mattos ÂZ; Debes JD; Boonstra A; Yang JD; Balderramo DC; Sartori GDP; de Mattos AA
    World J Gastroenterol; 2021 Jun; 27(24):3556-3567. PubMed ID: 34239269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain.
    Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
    Hepatol Int; 2022 Oct; 16(5):1161-1169. PubMed ID: 35666390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of chronic hepatitis B in severe liver disease.
    Fung J; Lai CL; Yuen MF
    World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chilean experience in liver transplantation for acute liver failure in children.
    Uribe M; Alba A; Hunter B; Valverde C; Godoy J; Ferrario M; Buckel E; Cavallieri S; Rebolledo R; Herzog C; Calabrán L; Flores L; Soto P
    Transplant Proc; 2010; 42(1):293-5. PubMed ID: 20172334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.
    Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S
    Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis.
    Wong TC; Fung JY; Cui TY; Lam AH; Dai JW; Chan AC; Cheung TT; Chok KS; Ng KK; Lo CM
    J Hepatol; 2019 Jun; 70(6):1114-1122. PubMed ID: 30871981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation.
    Lee WC; Chou HS; Lee CS; Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chan KM
    J Viral Hepat; 2018 Jul; 25(7):874-877. PubMed ID: 29431877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fulminant viral hepatitis.
    Jayakumar S; Chowdhury R; Ye C; Karvellas CJ
    Crit Care Clin; 2013 Jul; 29(3):677-97. PubMed ID: 23830658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global burden of liver disease: 2023 update.
    Devarbhavi H; Asrani SK; Arab JP; Nartey YA; Pose E; Kamath PS
    J Hepatol; 2023 Aug; 79(2):516-537. PubMed ID: 36990226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.
    Ende AR; Kim NH; Yeh MM; Harper J; Landis CS
    J Med Case Rep; 2015 Jul; 9():164. PubMed ID: 26215390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of viral hepatitis in liver transplant recipients.
    Jeong SW; Choi Y; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):338-44. PubMed ID: 25548738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing etiologies and outcomes of acute liver failure: A perspective from Japan.
    Oketani M; Ido A; Tsubouchi H
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():65-71. PubMed ID: 21199516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global Epidemiology of Viral Hepatitis.
    Razavi H
    Gastroenterol Clin North Am; 2020 Jun; 49(2):179-189. PubMed ID: 32389357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.